Pathway Genomics participated this week in a panel at the American Society of Human Genetics (ASHG) 2012 Annual Meeting in San Francisco. The panel was focused on issues associated with perceptions of genetic testing, specifically when offered directly to the consumer.

Though Pathway’s genetic testing services are provided exclusively through physicians, the company participated due to its interest in advancing the field of genetic testing. “Concerns over genetic testing are often disproportionate to the reality,” Tanya Moreno, Ph.D., director of research and development at Pathway Genomics, said in Thursday’s panel.

“Concerns over genetic testing are often disproportionate to the reality,” said Tanya Moreno, Ph.D., director of research and development at Pathway Genomics

As Ricki Lewis, Ph.D., editor and writer of the PLoS blog DNA Science Blog: Genetics in Context, reports in her coverage of the conference, doubts are fading and people are “asking about expanding DTC services to more diverse communities.” Read more…

Comments are closed.